We report here a high-throughput method for the modification of bacterial artificial chromosomes (Bacs) that uses a novel two-plasmid approach. In this protocol, a vector modified in our laboratory to hold an r6Kγ origin of replication and a marker recombination cassette is inserted into a Bac in a single recombination step. temporal control of recombination is achieved through the use of a second plasmid, psV1.reca, which possesses a recombinase gene and a temperature-sensitive origin of replication. this highly efficient protocol has allowed us to successfully modify more than 2,000 Bacs, from which over 1,000 Bac transgenic mice have been generated. a complete cycle from Bac choice to embryo implantation takes about 5 weeks. Marker genes introduced into the mice include EGFP and EGFP-L10a. all vectors used in this project can be obtained from us by request, and the eGFp reporter mice are available through the Mutant Mouse regional resource center (nInDs/Gensat collection). cns anatomical expression maps of the mice are available to the public at http://www.gensat.org/.
IntroDuctIon
Transgenic animals generated from traditional constructs-e.g., pBR-type plasmids, cosmids and λ vectors, which hold between 10-and 50-kb DNA-often show incorrect temporal and cellspecific transgene expression. The average mammalian gene is ~30 kb in length, but sequences that control the proper expression of the gene may be positioned far upstream of the start site, far downstream of the poly(A) tail or even within introns. Therefore, transgene expression that mirrors expression of the native gene requires the entire transcription unit and surrounding intergenic regulatory DNA to be present on the construct used to generate the animal. Vectors with larger cloning capacity, such as bacterial artificial chromosomes (BACs), P1-derived artificial chromosomes (PACs) and yeast artificial chromosomes (YACs), have the ability to hold longer stretches of DNA but require more skill to engineer than do traditional constructs 1, 2 . The largest of these 'large' vectors, YACs, can, in theory, hold any mammalian gene (i.e., inserts up to 2,000 kb), but in practice YACs tend to be unstable and are often chimeric. Although they matured later than YAC technologies, BAC-based cloning strategies became popular because BAC constructs possess high clonal stability and low chimerism and are relatively easy to handle [3] [4] [5] [6] . Originally designed to allow cloning of large genomic DNA fragments for a variety of purposes [7] [8] [9] [10] [11] , the average BAC holds inserts of ~200 kb, a size that is usually sufficient to cover an entire transcriptional unit and its associated regulatory elements 3, 12 . What makes this vector the best choice for large-scale transgenic experiments is the ease with which it can be modified to incorporate DNA insertions, deletions or substitutions [13] [14] [15] [16] [17] . Almost all current BAC modification protocols use homologous recombination strategies that complement the RecA deficiency of the BAC host strain. Controlled recombination is performed by using exogenous RecA 13, 16 or RecA-like proteins from a variety of sources, e.g., recE/recT (from Rac prophage) 18 and Redα(exo), Redβ(bet) and Redγ(gam) (from bacteriophage-λ) [19] [20] [21] . The protocol laid out in this paper is a modification of our previous protocol in which we use the pLD53.SC-AB plasmid to modify BACs 16 . pLD53.SC-AB contains an R6Kγ origin of replication (R6Kγ ori) 22 , an ampicillin-resistance gene for positive selection, a sacB gene for negative selection 23 , a recombination cassette and a recA gene. The original protocol involved the cloning of two homology arms, two recombination steps and the growth of bacteria on agar and sucrose to eliminate those carrying unresolved BACs. The present protocol describes a method for modifying BACs that is about 2 weeks shorter than that previously published 16 . Using this rapid method, The GENSAT Project at The Rockefeller University has modified more than 2,000 BACs and has generated over 1,000 BAC transgenic mice since 2002 (ref. 24) . Scientific publications that have cited The GENSAT Project or made use of GENSAT BAC transgenic mice can be found in the following link: http:// www.gensat.org/gensat_papers_report.jsp. Key steps in the BAC modification process are described below.
Experimental design
Choosing a BAC. The first step in our BAC modification protocol is the selection of a BAC clone that contains a gene of interest (see Fig. 1 for an overview of the modification process). Depending on the size of the gene, there are usually half a dozen or more BACs that cover the coding sequence. Public access to genome databases such as the University of California Santa Cruz (UCSC) Genome Browser, NCBI Clone Registry and the Ensembl Genome Browser have greatly improved the identification of appropriate BAC clones. As part of our selection criteria, we choose a BAC only if it is listed in at least two of the aforementioned databases. An ideal clone will have the gene of interest flanked by at least 50 kb of DNA at both the 5′ and 3′ ends. The inclusion of large regions of genomic sequence around the transgene helps to support proper expression in vivo. If the gene is asymmetrically located within the insert, i.e., if there is very little 5′ or 3′ flanking DNA present, then expression may not be accurate. Genes larger than 150 kb, e.g., mouse genes encoding cadherin-2 (220 kb), ataxin-1 (410 kb) and synaptotagmin-I (512 kb), are not good candidates for BAC transgenesis, as regulatory sequences are not likely to be carried on the BAC. There are many commercial sources for BACs, which can be purchased as libraries or as individual clones. The BACs used by our laboratory (most often C57BL/6J mouse, occasionally human) are purchased from the Children's Hospital Oakland Research Institute (BACPAC Resources at CHORI) and from the RIKEN BioResource Center. We currently own two mouse libraries, RPCI-23 and RPCI-24, which trace their origin to the Roswell Park Cancer Institute. All BACs possess a chloramphenicol-resistance gene and are maintained in DH10B host bacteria. In general, the choice of an appropriate BAC is an educated guess; at this time we simply do not know where the regulatory elements for most genes reside. For this reason, we choose the BAC that contains the most intergenic DNA between the gene of interest and its neighbors. We have noticed, however, that our rules for picking BACs are less useful when dealing with complex genetic loci containing closely apposed gene families, such as protocadherin and Hox genes. In some cases, genes other than the one to be targeted are present on the BAC. These passenger genes, if expressed in the transgenic organism, can result in an unwanted phenotype. We advise that investigators examine the BAC for the existence of other genes, particularly if the gene to be modified is small (1-10 kb), and then consider experimental needs before deciding to proceed. In the case of small genes, a smaller BAC that will contain fewer passenger genes can be chosen.
A two-plasmid approach: separation of recA and the recombination cassette. Key to the success of this BAC modification protocol is the use of two separate plasmids: a conditionally replicating vector, pLD53.SC2, which contains a selectable marker and has an R6Kγ DNA origin of replication (R6Kγ ori), and a pSV1.RecA plasmid, which contains a recA gene and has a temperature-sensitive origin of replication (ts-ori) (Fig. 2) 13 . This represents a major change from our previous protocol, in which the recA gene and the recombination cassette were on the same plasmid. The advantage provided by the use of two plasmids is that RecA expression can be controlled independently of the recombination cassette. Although RecA, or another RecA-like protein, is absolutely required for recombination to occur between the pLD53.SC2 plasmid and the BAC, constitutive expression of the gene can cause unwanted rearrangements of BAC DNA. The presence of a ts-ori on the pSV1.RecA plasmid allows this plasmid to be turned on when needed and eliminated after recombination is completed.
Plasmid specifics. The pLD53.SC2 plasmid has been modified by our laboratory to hold genes for either enhanced green fluorescent protein (EGFP) or EGFPribosomal fusion protein (EGFP-L10a). AscI and SwaI cloning sites on the modified plasmid serve as insertion points for a homology arm that will allow the transgene to be inserted into a BAC. The presence of an R6Kγ ori on the plasmid means that replication of this construct can only occur in In this figure, the gene-specific A-homology arm has already been cloned into the EGFP-containing pLD53.SC2 (described in the protocol). Homologous recombination between pLD53.SC2/A-box and the BAC (a supercoiled circular structure that is represented as a line here) requires a recombinase supplied by pSV1.RecA. After recombination is complete, incubation of bacteria with chloramphenicol, ampicillin and tetracycline (chlor/amp/tet) results in the selection of bacteria that contain a correctly modified BAC. Free pLD53.SC2/A-box remaining in the BAC host bacteria will also be eliminated because of the lack of pi protein required for replication. A second incubation of the bacteria at 43 °C will result in the elimination of pSV1.RecA, as it cannot replicate at this temperature. The presence of the pLD53.SC2 sequence on the BAC does not interfere with the transgene expression or with viability in the animals generated. Confirmation of successful BAC modification as well as organism genotyping can be carried out by PCR amplification of the areas indicated by pink arrows, 5′ forward cointegrate (5′ FC) and 3′ reverse marker primers (3′ RM), and blue arrows, 5′ forward R6Kγ ori (5′ FR6) and 3′ reverse cointegrate (3′ RC) primers.
the presence of a pi protein, which is not generated by the BAC host cells. Amplification and engineering of pLD53.SC2 must therefore be carried out in a bacterial strain that possesses the pir gene that codes for the pi protein. We use PIR1 or PIR2 strains of Escherichia coli for this purpose. For recombination to occur between a BAC and pLD53.SC2, a homology arm and a recombinase enzyme must be present. The BAC host bacterial strain, DH10B, carries a mutated recA gene that is inactive. To compensate for this deficiency, RecA or another RecA-like enzyme must be supplied. In this protocol, RecA is supplied by pSV1.RecA, which possesses a ts-ori that only functions well at 30 °C. Recombination, therefore, can be temporally controlled by increasing or decreasing culture temperature 13 . pSV1.RecA is ultimately lost when the bacteria are grown at 43 °C. Any pLD53.SC2 that has failed to integrate at the end of the experiment is also lost because DH10B does not produce pi protein and the plasmid cannot independently replicate in the DH10B host bacteria. The absence of free plasmid in host cells greatly reduces background. Both plasmids possess antibioticresistance genes (pLD53.SC2 has an ampicillin-resistance gene, pSV1.RecA has a tetracycline-resistance gene) that allow for quick and easy bacterial selection.
Genes inserted into the pLD53.SC2 vector. We have used both EGFP and EGFP-L10a as marker genes, depending on the aim of the experiment.
(i) EGFP: EGFP is a chromophore-containing protein that is 238 amino acids in size and fluoresces if excited at 490 nm. If the number of EGFP molecules translated by a cell is sufficient (this depends on the strength of the promoter driving expression and number of copies inserted), epifluorescence can be directly visualized in living or fixed tissue 25 . If intrinsic fluorescence is not strong enough to be seen in a cell, the EGFP signal can be amplified by immunostaining with specific antibodies.
(ii) EGFP-L10a: For the purpose of isolating mRNA from specific cell types, we fused the ribosomal protein Rpl10a with EGFP and created a fusion reporter that can be expressed under the regulatory control of a chosen gene 26, 27 . If a gene of interest is expressed by a particular cell, the EGFP-L10a fusion molecule will be present in the ribosomes of this cell. Through the use of EGFP immunoprecipitation, the ribosomes and the mRNAs contained within can be isolated. This cell-specific mRNA can be studied by DNA microarray or sequencing technology. This approach to studying gene expression is particularly useful when working with cells that are few in number or are located among other cell types and, therefore, difficult to isolate.
BAC modification. The first requirement for homologous recombination is that a small homology arm be cloned into a pLD53.SC2 plasmid that carries either an EGFP or EGFP-L10a gene. Homologous stretches of DNA in both the BAC of interest and the pLD53.SC2 plasmid dictate the location at which recombination, and therefore the plasmid/transgene's placement, will occur. In most cases, the homology arm chosen for recombination is a 250-500 bp region of DNA located directly upstream of the ATG start site of the gene on the BAC. This site, referred to as an A-homology arm or A-box, is PCR amplified with primer sequences that are 25-30 bp in length (see Fig. 3 for a diagrammatic representation of an A-box). For cloning steps, a key step in the design of the forward 5′ A-box primer is the addition of an AscI or MluI enzyme recognition site at the 5′ end of the primer (AscI = 5′-GGCGCGCC-3′ and MluI = 5′-ACGCGT-3′). The reverse primer is a sequence that is located directly upstream of the ATG start site of the coding sequence and the forward primer is located ~250-500 bp further upstream. In rare cases, template sequences that are rich in GC content cannot be amplified because of the formation of secondary structures. In these circumstances, we synthesize an 80-90-bp oligonucleotide that can serve as a homology arm. The A-homology arm is digested with a specific restriction enzyme and cloned into a similarly digested pLD53.SC2 plasmid. The modified pLD53.SC2 now holds a marker flanked by a region homologous to the region directly upstream of the start site of a gene of interest. It is through this physical arrangement that the pLD53.SC2 vector can be used to place the EGFP or EGFP-L10a gene (or any other cDNA) at the start site of the gene of interest on the BAC. The regulatory elements that would normally drive the transcription of the gene of interest now drive expression of a transgene. The endogenous gene on the BAC will not be expressed because a poly(A) tail is attached to the EGFP or EGFP-L10a. We refer to the modified BAC as a cointegrate. The use of nonresolved BACs in the transformation process has proven to greatly reduce the time needed to generate transgenic mice. As expected, the presence of plasmid sequences in the modified BAC has been shown not to interfere with transgene expression or mouse viability. For experiments in which the investigator wishes to avoid incorporation of plasmid sequences into the BAC, our original two-step approach using the pLD53.SC-AB plasmid can be used 16 .
BAC DNA preparation and microinjection. One of the most important steps in creating BAC transgenic organisms is the use of good-quality DNA for pronuclear injection. Although BAC DNA is stable inside its host cell, the constructs are very large (~200,000 bp) and susceptible to mechanical shear and enzymatic degradation once outside a cell. Several protocols have been published on how to prepare BAC DNA for microinjection into fertilized eggs [28] [29] [30] . The purification method described here uses both CsCl gradient centrifugation and membrane dialysis. These methods yield intact and clean BAC DNA that, when injected into pronuclei of fertilized mouse oocytes (we use FVB/N zygotes) by a skilled microinjectionist, results in litters in which 17-19% of the pups are positive for the transgene. The location where the BAC inserts in a chromosome is random. The BAC may insert into any one of the 38 autosomes or 2 sex chromosomes. A chance insertion into the Y chromosome will result in all male progeny of the founder being transgenic, whereas all female progeny will be wild type. (Genotyping in this case is easy.) Infrequently, BACs may integrate after the nuclear DNA has replicated. If this happens, the transgene will not be present in all cells and the founder will be mosaic.
Experimental timeline and applications. Although having a basic knowledge of molecular techniques will be helpful to the investigator wishing to generate transgenic animals, this protocol is a step-by-step guide that includes instructions on how to pick a BAC, prepare plasmid and BAC DNA in bulk, transform bacteria, carry out homologous recombination and purify DNA for pronuclear injection (for an overview, see Fig. 1 ). Special emphasis is placed on areas in which the investigator is most likely to encounter problems. Although it is beyond the scope of this paper to include the actual details for generating transgenic mice, a complete cycle from BAC choice to embryo implantation takes ~5 weeks, with 2.5-3 of these weeks devoted to BAC modification. Some portions of the procedure can be run concurrently. Our laboratory completes 9-10 BAC modification cycles per year, and each technician is usually able to successfully modify about half of the 20 BACs assigned to him or her per cycle. Using the modification method described in this paper, we have successfully engineered more than 2,000 BACs and have produced over 1,000 BAC transgenic mice bearing EGFP and EGFP-L10a transgenes 24, 26, 27, 31, 32 . This BAC modification method can also be used to generate other transgenic lines that carry genes such as td-tomato, lacZ and Cre and Flpe recombinase. In addition, BACs modified with the currently described protocol can be used to generate mice that overexpress mutant or wild-type genes. Expression is also seen in interneurons in the molecular layer. Scale bars, 100 µm. Tris-EDTA buffer (1× TE) Add 10 ml of 1 M Tris and 2 ml of 0. ; LB agar-chlor20 plate), ampicillin (30 µg ml chosen by hand. The reverse 3′ primer is a sequence that is located directly upstream of the ATG start site of the gene and the forward 5′ primer is located ~250-500 bp further upstream. For cloning steps, a key step in the design of the forward 5′ A-box primer is the addition of an AscI or MluI enzyme recognition site at the front of the primer (AscI = 5′-GGCGCGCC-3′ and MluI = 5′-ACGCGT-3′). See Figure 3 for further explanation. This same 5′ A-box primer with added enzyme site can be used in noncloning PCR steps as well. To analyze the modified BAC, two PCRs are run at the same time. The first set of primers consists of a forward 5′ cointegrate primer, which is located 80-100 bp upstream of the A-box, and a reverse 3′ marker primer of the reporter in the construct (reverse 3′ EGFP: 5′-CGCCCTCGCCGGA CACGCTGAAC-3′ or reverse 3′ EGFP-L10a: 5′-CAGGGTGTCGCGTGAG ACTTTGCTGC-3′). The second set of primers used consists of a forward 5′ R6Kγ ori (forward 5′ R6Kγ ori 5′-CAGGTTGAACTGCTGATCTTCAGATC CTC-3′) and a reverse 3′ cointegrate primer, which is located 80-100 bp downstream of the A-box. Pulsed-field gel electrophoresis Add 2 g of agarose to 180 ml of dH 2 O and mix by swirling. Heat the solution in the microwave for 4 min. Add 20 ml of 5× TBE and further mix by swirling. Pour the 1% (wt/vol) agarose solution into a pulsed-field gel mold and allow it to polymerize. Transfer the gel to the gel box and insert 2 mm of a low-range PFG Marker DNA ladder gel into one well. Ensure that there are no bubbles. Load 10 µl of samples into other wells. Cover the gel with 0.5× TBE and run it at 16 °C in a CHEF-DR III (Bio-Rad) system at 6 V cm proceDure amplification and purification of plasmids • tIMInG 2 d 1| Add plasmids to competent cells. Use option A to amplify the pLD53.SC2 vector, which requires the pi protein to replicate and must be grown in PIR1-or PIR2-competent E. coli. Our preference is PIR1. PIR1 cells are able to maintain about 250 copies of the donor vector, whereas PIR2 cells can maintain about 15 copies of the donor vector. Use option B to amplify the pSV1.RecA vector, which has a temperature-sensitive origin of replication and can be grown in most competent bacteria at 30 °C. We use DH5α-competent cells. These cells are commercially available and grow well in culture. Option A and option B should be carried out in parallel.  crItIcal step Your work environment needs to be extremely clean. We usually clean the centrifuge, bench and pipettes with 70% (vol/vol) ethanol before working with plasmids. Incubate for 8 h at 30 °C. (vii) Transfer this culture into a 2,000-ml Erlenmeyer flask containing 500 ml of LB broth-tet10 and incubate it for 14-16 h at 30 °C with rotation at 300 r.p.m.  crItIcal step Bulk preparation of plasmid saves a significant amount of time if your goal is to modify multiple BACs.
2|
Transfer the bacterial cultures from Steps 1A(vii) and 1B(vii) to independent 1,000-ml polypropylene bottles and harvest the cells by centrifugation at 4,552g (J6-MI Beckman-Coulter centrifuge, JS-4.2 rotor) for 30 min at 4 °C. Process the pellets in parallel as described in Steps 3-18 below.
3|
Discard the supernatant and resuspend each bacterial pellet in 30 ml of P1 buffer.
4| Add 30 ml of P2 buffer to the mixture to lyse the bacteria. Gently mix and incubate for 5 min at room temperature.
5| Add 30 ml of ice-cold P3 buffer to the lysate to neutralize it. Gently mix and incubate for 20 min on ice.
6|
Centrifuge the mixture at 20,369g (J-25I Beckman Avanti centrifuge, JLA-16.250 rotor) for 30 min at 4 °C.
7|
To precipitate the DNA, transfer the supernatant into a polypropylene 250-ml wide-mouth bottle containing 63 ml of isopropanol and mix it by inverting several times.
8|
Centrifuge at 4,552g (J6-MI Beckman-Coulter centrifuge, JS-4.2 rotor) for 30 min at 4 °C.
9|
Discard the supernatant and wash the pellet with 70% (vol/vol) ethanol.
10| Air-dry the pellet for 10 min at room temperature and resuspend it in 5 ml of 1× TE buffer.
11|
Extract the DNA from the mixture with equal volumes of phenol/chloroform by shaking for 5 min on a rotating platform. 15| Air-dry the pellet for 10 min at room temperature and resuspend it in 400 µl of 1× TE buffer.  pause poInt The resuspended pellet can be stored for several months at 4 °C, if required.
16|
Prepare Chroma Spin + TE-400 columns as directed in the manufacturer's instructions.  crItIcal step Do not substitute with another purification column. These columns produce the best results, by far.
17|
Carefully apply no more than 200 µl of DNA into the center of the column. Two columns are required to purify 400 µl of plasmid. Do not allow any sample to flow along the wall of the column, or else the purification of the sample will not be complete. Centrifuge at 700g (J6-MI Beckman-Coulter centrifuge, JS-4.2 rotor) for 5 min at 4 °C. The buffer in the collection tube contains the purified pLD53.SC2 or pSV1.RecA DNA. 24| Purify the digested vector by running the sample through a 1% (wt/vol) low-melting-temperature agarose gel. Visualize the band under UV light and cut it from the gel. Aliquot 2-mm blocks of the sample into 1.5-ml Eppendorf tubes. This is the digested pLD53.SC2 to be used in Step 49. 34| Discard the supernatant and wash the pellet with 70% (vol/vol) ethanol. Air-dry the pellet for 10 min at room temperature.
35|
Resuspend the pellet in 50 µl of 1× TE buffer. This buffer contains the supercoiled circular BAC DNA.  crItIcal step The BAC DNA should only be stored at 4 °C (maximum 6 months). Do not store the DNA in the freezer. You will ruin it.
36|
Confirm the identity of the amplified BAC by PCR. This is particularly important if choosing BACs from a library. For each BAC to be tested, try two different PCR conditions. Depending on the GC content of the templates, one condition will yield better results than the other. Set up reactions as described below. See table 1 for a description of the primers required. 
47|
Purify the digested fragments with a QIAquick PCR Purification Kit (or gel elution where necessary). This is the digested A-homology arm (A-box).
48|
To assess concentration, mix 1 µl of digested A-box fragments with 9 µl of 1× TE and 1 µl of 10× DNA-loading dye. Analyze on a 1.1% (wt/vol) agarose gel stained with ethidium bromide. Use a 2-log DNA ladder and a λ-DNA-HindIII digest as molecular weight markers.  pause poInt The digested A-box DNA can be stored for several years at − 20 °C.
cloning of the a-homology arm (a-box) into plD53.sc2 • tIMInG 2 d 49| Warm an aliquot of the digested pLD53.SC2 from Step 24 for 10 min in a 65 °C water bath to melt the agarose in which the sample is stored. Ensure that the agarose is completely melted.  crItIcal step Reagents must be added in the order described in Steps 50-52 or ligation will not work.
50| Transfer 100 ng of the digested A-box from
Step 48 (4-8 µl, volume depends on the concentration) to a 1.5-ml Eppendorf tube and add dH 2 O to adjust the volume to 15 µl.
51|
To the digested A-box, add 2 µl of the heated pLD53.SC2 (~100 ng) vector from Step 49 and allow the mixture to cool. Cooling is very important to avoid denaturing the T4 DNA ligase used in Step 52.
52| Thaw a tube of T4 reaction buffer and vortex it well. Add 2 µl of T4 reaction buffer to the tube containing the digested A-box and pLD53.SC2 and then add 1 µl of T4 DNA ligase. Mix by gently tapping the sides of the tube with your finger. Mix thoroughly but gently. Spin briefly and cover with aluminum foil.
53|
Incubate the ligation mixture at room temperature for a minimum of 2-3 h. The incubation can run overnight if desired.
54| Thaw a single aliquot of PIR1-competent E. coli on ice. To a new 1.5-ml Eppendorf tube, add 4 µl of the pLD53.SC2/ A-box ligation mix and 12-16 µl of PIR1 cells. Mix the tube gently and incubate for 30 min on ice.  crItIcal step The pi protein produced by the PIR1 bacteria is critical for the replication of the pLD53.SC2 plasmid. Do not use another type of bacteria; the experiment will not work.
55|
Heat shock the PIR1 bacteria and plasmid mixture step by placing the tube in a 42 °C water bath for 50 s. Immediately place it back on ice for 1 min.  crItIcal step Use a timer for this step. Heat shocking the bacteria longer than this time will reduce transformation efficiency.
56| Add 100 µl of S.O.C. medium to the tube and incubate for 1 h in a 37 °C water bath.
57| Spread 100 µl of the transformed PIR1 bacteria containing the pLD53.SC2/A-box vector onto an LB agar-amp30 plate. Incubate the plate overnight at 37 °C.
58|
Use PCR to check 8-10 individual PIR1 colonies for the presence of the modified pLD53.SC2/A-box vector. To check a colony, remove half of it with a sterile yellow pipette tip and mix it with 15.9 µl of dH 2 O to prepare a suspension. Set up reactions as detailed below. See table 1 for a description of the primers required. Step 57. Inoculate 20 ml of LB broth-amp30 and incubate overnight at 37 °C with rotation at 300 r.p.m.
62|
Harvest the cells by centrifuging at 4,552g (J6-MI Beckman-Coulter centrifuge, JS-4.2 rotor) for 15 min at 4 °C.
63|
Discard the supernatant and resuspend the bacterial pellet in 500 µl of P1 buffer.
64|
Add 500 µl of P2 buffer to the mixture to lyse the bacteria. Gently mix and incubate the mixture for 5 min at room temperature.
65|
Add 500 µl of ice-cold P3 buffer to the lysate to neutralize it. Gently mix. 75| Run the entire volume of both samples on a 1.5% (wt/vol) agarose gel stained with ethidium bromide. Use a 2-log DNA ladder as a molecular weight marker. The unmodified plasmid will be represented by a single band. A successfully modified pLD53.SC2 will be represented by two bands. The lower band will be the size of the A-box. The higher band will be the size of the unmodified pLD53.SC2. See Figure 5 for examples of digested pLD53SC2/A-box DNA.
preparation of Bac host cells chemically transformed with psV1.reca • tIMInG 3 d 76| Pick a single colony from the LB agar-chlor20 plate made in Step 25 and inoculate 5 ml of LB broth-chlor20 in a 14-ml Falcon tube. Grow the cells overnight at 37 °C with shaking at 300 r.p.m.
77|
Dilute the overnight culture 1:100 with LB broth-chlor20 and incubate for 3-4 h at 37 °C. Check cell density with a spectrophotometer. Grow to an optical density at 600 nm (OD 600 ) of 0.6-0.8.
78|
Harvest the cells by centrifugation at 2,560g (J6-MI Beckman-Coulter centrifuge, JS-4.2 rotor) for 10 min at 4 °C.
79|
Discard the supernatant and resuspend the bacterial pellet in 5 ml of ice-cold 50 mM CaCl 2 . Place the tube on ice for 15 min and repeat
Step 78 once.
80|
Resuspend the pellet in 300 µl of an ice-cold solution of 50 mM CaCl 2 and 20% (vol/vol) glycerol and aliquot 100 µl into three tubes.  pause poInt Store two of these tubes at − 80 °C. If the pSV.RecA transformation performed in Steps 81-84 does not work, these samples can be used to repeat the process.
81|
Thaw an aliquot of pSV1.RecA DNA made in Step 18 and add 2-5 µl of this plasmid DNA to 100 µl of the BAC-competent cells from
Step 80. Mix the tube gently and incubate for 30 min on ice.
82|
Heat shock the bacteria and plasmid mixture by placing the tube in a 42 °C water bath for 50 s. Immediately place the mixture back on ice for 1 min.  crItIcal step Use a timer for this step. Heat shocking the bacteria for longer than this time will reduce transformation efficiency.
83| Add 1.0 ml of S.O.C. medium to the mixture, transfer into a 15-ml Eppendorf tube and incubate for 1 h at 30 °C with shaking at 220 r.p.m.
84|
Prepare two LB agar plates containing both chlor20 and tet10. Spread one with 5 µl of the transformed BAC cells and the other with 100 µl of the transformed BAC cells. Incubate overnight at 30 °C.  crItIcal step Do not incubate at 37 °C. This temperature will inhibit the replication of pSV.RecA.
85|
Pick a single colony from the lower-density plate and inoculate it in 5 ml of LB broth containing both chlor20 and tet10. Incubate overnight at 30 °C with shaking at 300 r.p.m.
86|
Transfer 1 or 2 ml of overnight culture into 50 ml of LB broth both chlor20 and tet10 in a 250-ml Corning centrifuge tube. Grow cells for 4-5 h with vigorous shaking at 30 °C. Check cell density with a spectrophotometer. Grow cells to an OD 600 of 0.6-0.8. Transfer cells into 50-ml Falcon tubes.  crItIcal step Do not incubate at 37 °C. This temperature will inhibit the replication of pSV.RecA. 93| After electroporation, add 1 ml of S.O.C. medium to the cuvette and transfer the cell suspension to a 15-ml tube.
Incubate the sample for 1 h at 30 °C with shaking at 220 r.p.m.  crItIcal step Do not incubate at 37 °C.
94| Add 5 ml of LB broth containing chlor20 and amp50 and tet10 to the culture in Step 93 and incubate overnight at 30 °C. Only bacteria containing correctly modified BACs and copies of pSV1.RecA will be selected. Unmodified BACs (i.e., those lacking a pLD53.SC2/A-box insert) will be eliminated by exposure to ampicillin. Free pLD53.SC2/A-box remaining in the BAC host bacteria will also be eliminated, as this vector requires the pi protein to replicate.
95|
Prepare two LB agar plates containing both chlor20 and amp50. Spread one with 20 µl of the overnight culture and the other with 100 µl of the overnight culture and incubate overnight at 43 °C. One of the plates will likely provide better colony resolution than the other. Free pSV1.RecA remaining in the BAC host bacteria cannot replicate at 43 °C and will be eliminated. 
96|

119|
Check the DNA on a pulse field gel to determine its quality and concentration. See Figure 6 for an example of an optimal pulse field gel result.  crItIcal step The BAC DNA should only be stored at 4 °C. Freezing the DNA will destroy it. The tube should be kept away from light.  pause poInt BAC DNA can be stored at 4 °C for up to 6 months. ? trouBlesHootInG 120| Before microinjection of oocytes, BACs holding an EGFP or EGFP-L10a transgene should be linearized with the use of the endonuclease PI-SceI. Linearizing BAC DNA has been demonstrated to increase integration into genomic DNA by threefold 33 . Add 100-200 ng of BAC DNA, 2 µl of PI-SceI, 5 µl of NE 10× buffer and dH 2 O to an Eppendorf tube to produce a final volume of 50 µl. Gently mix and incubate for 5-6 h at 37 °C.
121| Place 20 ml of injection buffer into a sterile Petri dish and float a 25-mm, 0.025-µm-pore Millipore filter on top with the shiny side up. Load the 50 µl of linearized BAC DNA from Step 120 onto the filter and cover the Petri dish with a lid. Allow to sit for 4-6 h at room temperature.
122|
Transfer the DNA-containing solution on top of the filter to a microcentrifuge tube and add enough injection buffer to return the solution to the original volume of 50 µl.
123|
Check the DNA on a pulsed-field gel to determine the concentration (see REAGENT SETUP).  pause poInt The DNA should be stored at 4 °C until injected into oocytes. The lag time between dialysis and use should be no more than 7 d.  crItIcal step The BAC DNA should only be stored at 4 °C. Freezing the DNA will destroy it. ? trouBlesHootInG 124| Before injection, dilute the DNA with an appropriate amount of injection buffer so that the concentration is 0. antIcIpateD results This protocol has been used to modify more than 2,000 BACs and generate more than 1,000 transgenic mice. The efficiency of BAC recombination using this system can vary from 70-100%. Our current success rate in generating transgenic mice from modified BAC DNA using the procedure described is 17-19%. Although the expression pattern observed in BAC transgenic mice most often mirrors expression patterns observed in in situ hybridization and immunohistochemical studies, occasionally, we observe higher or lower expression that other studies have reported for a particular gene. Greater expression may be the result of multiple BAC copies being present in the genome. Lesser expression may be due to the fact that important regulatory elements may be missing from a BAC. Examples of expression observed in six different BAC transgenic mouse lines generated in our laboratory are shown in Figure 4 . Individual cell types can be clearly identified and include projection neurons (Fig. 4a,e) , interneurons (Fig. 4f) , neuronal progenitors (Fig. 4f) , astroglia (Fig. 4c) , microglia (Fig. 4e) , vascular cells ( Fig. 4c ) and epithelial cells (Fig. 4b) . Cellular processes such as neuronal axons can also be seen (Fig. 4d) . These images show direct EGFP epifluorescence; no antibodies were used. . If DNA remains too sticky or particulate at the most dilute concentration, prepare again from Steps 120 to 125. In our experience, the ease with which DNA can be injected is linked to the quality of the DNA. Taking time to produce clean and nonsticky DNA assures that the highest number of transgenic mice will be produced
126
No transgenic mice are produced after zygote injection with modified BAC BAC DNA is of poor quality Prepare DNA again from Steps 100 to 125
